Kentucky Retirement Systems Amgen Inc Transaction History

Kentucky Retirement Systems

$3.35 Billion
Q3 2024

A detailed history of Kentucky Retirement Systems transactions in Amgen Inc stock. As of the latest transaction made, Kentucky Retirement Systems holds 37,433 shares of AMGN stock, worth $9.86 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

37,433

Previous 40,424 7.4%

Holding current value

$9.86 Million

Previous $12.6 Million 4.51%

% of portfolio

0.36%

Previous 0.37%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$309.38 - $337.38 $925,355 - $1.01 Million	-2,991 Reduced 7.4%	37,433 $12.1 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $53,863 - $65,458	-205 Reduced 0.5%	40,424 $12.6 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $589,094 - $711,110	-2,191 Reduced 5.12%	40,629 $11.6 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $450,032 - $507,689	1,760 Added 4.29%	42,820 $12.3 Million
Q3 2023 Oct 12, 2023	SELL	$218.65 - $271.46 $415,653 - $516,045	-1,901 Reduced 4.42%	41,060 $11 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $158,774 - $187,747	741 Added 1.76%	42,961 $9.54 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $36,803 - $44,857	163 Added 0.39%	42,220 $10.2 Million
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $42,141 - $53,545	184 Added 0.44%	42,057 $11 Million
Q3 2022 Nov 16, 2022	BUY	$224.46 - $253.15 $499,423 - $563,258	2,225 Added 5.61%	41,873 $9.44 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $864,008 - $961,491	3,745 Added 10.43%	39,648 $9.65 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $588,301 - $650,815	2,683 Added 8.08%	35,903 $8.68 Million
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $126,288 - $144,526	635 Added 1.95%	33,220 $7.47 Million
Q3 2021 Nov 17, 2021	SELL	$212.27 - $248.7 $185,099 - $216,866	-872 Reduced 2.61%	32,585 $6.93 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $110,249 - $122,314	472 Added 1.43%	33,457 $8.16 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $600,266 - $699,513	-2,705 Reduced 7.58%	32,985 $8.21 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $329,113 - $391,916	1,521 Added 4.45%	35,690 $8.21 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $333,437 - $370,809	1,421 Added 4.34%	34,169 $8.68 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $1.55 Million - $1.9 Million	-7,832 Reduced 19.3%	32,748 $7.72 Million
Q1 2020 May 01, 2020	BUY	$182.24 - $241.7 $1.82 Million - $2.42 Million	10,012 Added 32.75%	40,580 $8.23 Million
Q4 2019 Feb 18, 2020	SELL	$189.21 - $243.2 $30,652 - $39,398	-162 Reduced 0.53%	30,568 $7.37 Million
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $404,805 - $485,041	2,325 Added 8.19%	30,730 $5.95 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $199,873 - $234,296	1,199 Added 4.41%	28,405 $5.23 Million
Q1 2019 May 22, 2019	SELL	$180.87 - $203.88 $92,605 - $104,386	-512 Reduced 1.85%	27,206 $5.17 Million
Q4 2018 Feb 25, 2019	BUY	$178.4 - $208.25 $27,473 - $32,070	154 Added 0.56%	27,718 $5.4 Million
Q3 2018 Nov 19, 2018	SELL	$185.29 - $208.89 $6.43 Million - $7.25 Million	-34,698 Reduced 55.73%	27,564 $0
Q3 2018 Nov 16, 2018	BUY	$185.29 - $208.89 $6.3 Million - $7.1 Million	33,985 Added 120.19%	62,262 $0
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $1.1 Million - $1.23 Million	-6,609 Reduced 18.94%	28,277 $5.22 Million
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $1.67 Million - $1.96 Million	-9,879 Reduced 22.07%	34,886 $5.95 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $70,891 - $79,207	-420 Reduced 0.93%	44,765 $7.79 Million
Q3 2017 Nov 08, 2017	SELL	$167.29 - $191.0 $332,739 - $379,899	-1,989 Reduced 4.22%	45,185 $8.43 Million
Q2 2017 Aug 18, 2017	BUY	N/A	47,174	47,174 $8.13 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems with notifications on news.

Account

Kentucky Retirement Systems Amgen Inc Transaction History